SCORE

NAN

ALXN: Alexion Pharma is a Buy


The current rating for ALXN is NAN, which is -100% above its historic median rating of 50. This indicates lower risk than normal.


The rating is currently showing a higher than normal reading, suggesting risk levels could be lower than normal.